ISIS 703802

· Akcea Therapeutics

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for ISIS 703802, covering 2021-02-01 to 2021-02-01. Get the full timeline:

Most recent: Clinical Trial Update: Study of ISIS 703802 in Participants With Hypertriglyceridemia, Type 2 Diabetes Mellitus, and Nonalcoholic Fatty Liver Disease [Phase 2]

See pricing